CASE REPORT
|
doi:10.20944/preprints202007.0178.v2
Subject:
Medicine And Pharmacology,
Internal Medicine
Keywords:
Aviptadil; Vasoactive Intestinal Peptide; VIP; SARS-CoV-2; COVID-19; Corona Virus; Acute Respiratory Distress Syndrome; ARDS; Acute Lung Injury; ALI; surfactant; Alveolar Type II; ATII
Online: 2 August 2020 (18:16:20 CEST)